Breaking News
Get 40% Off 0
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did. Read how
Close

Orion Pharma Ltd (ORIO)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
72.00 -1.10    -1.50%
08/05 - Closed. Currency in BDT ( Disclaimer )
  • Volume: 1,845,357
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 71.10 - 73.40
Type:  Equity
Market:  Bangladesh
ISIN:  BD0486OPL004 
S/N:  ORIONPHARM
Orion Pharma 72.00 -1.10 -1.50%

DH:ORIO Financials

 
This summary provides an overview of the most significant critical numbers from each of the Orion Pharma Ltd financial reports, including theOrion Pharma Ltd income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health.

Investors can select to view data from four periods of either annual or quarterly information, allowing them to track the DH:ORIO financials over time via breakdowns of their annual reports.

Orion Pharma Limited reported earnings results for the third quarter and nine months ended March 31, 2024. For the third quarter, the company reported sales was BDT 2,035.3 million compared to BDT 2,297.65 million a year ago. Net income was BDT 99.22 million compared to BDT 123.87 million a year ago. Basic earnings per share from continuing operations was BDT 0.42 compared to BDT 0.53 a year ago.For the nine months, sales was BDT 7,780.5 million compared to BDT 10,210.82 million a year ago. Net income was BDT 386.13 million compared to BDT 571.62 million a year ago. Basic earnings per share from continuing operations was BDT 1.65 compared to BDT 2.44 a year ago.

AnnualQuarterly  
Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

ORIO Income Statement & Profits

Gross margin TTM 18.85%
Operating margin TTM 5.97%
Net Profit margin TTM 3.96%
Return on Investment TTM 1.35%
 Total Revenue  Net Income
Period Ending: Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023
Total Revenue 2035.3 2135.55 3609.65 3715.77
Gross Profit 515.23 622.77 588.17 441.44
Operating Income 171.06 171.76 225.03 118.19
Net Income 99.22 110.18 176.73 69.33

ORIO Balance Sheet

Quick Ratio MRQ 0.41
Current Ratio MRQ 1.86
LT Debt to Equity MRQ 92.08%
Total Debt to Equity MRQ 102.67%
 Total Assets  Total Liabilities
Period Ending: Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023
Total Assets 52319.6 54419.37 54793.37 52939.68
Total Liabilities 29028.89 31901.77 32301.33 30605.63
Total Equity 23290.72 22517.61 22492.04 22334.06

%ENGLISH_NAME% Latest Cash Flow Statement

Cash Flow/Share TTM 6.9
Revenue/Share TTM 49.13
Operating Cash Flow  1.11%
 Cash  Net Change in Cash
Period Ending: Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities 96.41 -281.93 909.52 891.01
Cash From Investing Activities -7.88 -90.51 -833.57 -120.05
Cash From Financing Activities -16.88 314.52 -13.94 -1017.57
Net Change in Cash 71.64 -57.92 62.01 -246.61
* In Millions of BDT (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ORIO Price Commentary

Write your thoughts about Orion Pharma Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Md Jubayed
Md Jubayed Sep 16, 2022 10:08
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Now it’s uptrend and break out previous histry.
Md Jubayed
Md Jubayed Sep 16, 2022 10:08
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Now it’s uptrend and break out previous histry.
Md Jubayed
Md Jubayed Sep 16, 2022 10:07
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Now it’s uptrend and break out previous histry.
Sarwar Ahmed
Sarwar Ahmed Dec 05, 2021 12:17
Saved. See Saved Items.
This comment has already been saved in your Saved Items
It is an outstanding share .Proper time to buy it .
Zunaid Karim
Zunaid Karim Oct 26, 2021 5:41
Saved. See Saved Items.
This comment has already been saved in your Saved Items
it's an undervalued share.FV 150+ so there is enough time to buy it.
Zunaid Karim
Zunaid Karim Oct 26, 2021 5:41
Saved. See Saved Items.
This comment has already been saved in your Saved Items
it's an undervalued share.FV 150+ so there is enough time to buy it.
Mahbubul Alam
Mahbubul Alam Oct 02, 2021 6:45
Saved. See Saved Items.
This comment has already been saved in your Saved Items
110 by 1 week.
Mizanur Rahman Kiron
Mizanur Rahman Kiron Sep 29, 2021 9:36
Saved. See Saved Items.
This comment has already been saved in your Saved Items
suddenly can fall down any moment!
Mohammad Suman
Mohammad Suman Sep 29, 2021 8:47
Saved. See Saved Items.
This comment has already been saved in your Saved Items
May be broker behind the price hike.
Mohammad Suman
Mohammad Suman Sep 29, 2021 8:47
Saved. See Saved Items.
This comment has already been saved in your Saved Items
May be broker behind the price hike.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email